Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : RALA-mRNA Vaccine
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Invox Pharma
Deal Size : Undisclosed
Deal Type : Financing
Details : The investment will support growth of the company’s proprietary RALA platform with an immediate focus on pHion’s lead project, PTX_V1 (RALA-mRNA vaccine), a first-in-class therapeutic vaccine for the treatment of human papilloma virus related cancers...
Product Name : PTX_V1
Product Type : Vaccine
Upfront Cash : Undisclosed
January 06, 2023
Lead Product(s) : RALA-mRNA Vaccine
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Invox Pharma
Deal Size : Undisclosed
Deal Type : Financing